← Back to Search

Ga-PSMA-11 for Prostate Cancer

Phase 3
Waitlist Available
Led By Bennett Chin
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after administration and for 1 hour and 30 minutes afterwards
Awards & highlights

Study Summary

This trial is testing a new imaging technique to help with diagnosis and treatment of prostate cancer.

Eligible Conditions
  • Prostate Cancer
  • Prostate Adenocarcinoma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after administration and for 1 hour and 30 minutes afterwards
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after administration and for 1 hour and 30 minutes afterwards for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Adverse Events
Secondary outcome measures
Compare the Diagnostic Impact of 68Ga-PSMA-11 PET/CT Imaging Over Current Standard of Care Imaging Modalities.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Men with pathologically proven prostate adenocarcinomaExperimental Treatment1 Intervention
The intervention is a PET scan with the radiolabelled PSMA ligand, 68Ga-PSMA-11. The PET may be combined with a CT scan as a PET/CT or an MRI scan as PET/MRI. 68Ga-PSMA-11 PET/CT will be acquired using a modern digital GE PET/CT scanner or a modern digital PET / MRI scanner.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ga-PSMA-11
2021
Completed Phase 3
~40

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,728 Previous Clinical Trials
2,143,623 Total Patients Enrolled
13 Trials studying Prostate Cancer
2,987 Patients Enrolled for Prostate Cancer
Bennett ChinPrincipal InvestigatorColorado Research Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
~11 spots leftby Mar 2025